Serum Bupropion Levels in 2 Breastfeeding Mother-Infant Pairs
J Clin Psychiatry 2002;63(10):910-911
© Copyright 2017 Physicians Postgraduate Press, Inc.
Purchase This PDF for $40.00
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($86) or print + online ($156 individual).
With your subscription, receive a free PDF collection of the NCDEU Festschrift articles. Hurry! This offer ends December 31, 2011.
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Click here to login.
Did you forget your password?
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
Background: These are the first reported data on
bupropion and hydroxybupropion levels in infants whose treated
mothers were breastfeeding. The information will assist
physicians and parents in the risk-benefit decision-making
process for bupropion treatment during breastfeeding.
Method: Serum samples were obtained by
venipuncture from 2 mother-infant pairs. The serum was assayed
for levels of bupropion and its most active metabolite,
Results: Neither infant had quantifiable serum
levels of bupropion or its metabolite at steady state. Neither
infant had medical problems during the time of maternal therapy.
Conclusion: We recommend obtaining and
publishing additional serum level findings for breastfeeding
mother-infant pairs since data for bupropion are favorable but